US Patent Issued to GUANGZHOU REFORGENE MEDICINE, ZHEJIANG SYNSORBIO TECHNOLOGY on Aug. 4 for "Isolated CAS13 protein and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,492, issued on Aug. 4, was assigned to GUANGZHOU REFORGENE MEDICINE Co. LTD. (Guangzhou, China) and ZHEJIANG SYNSORBIO TECHNOLOGY Co. LTD (Shaoxing, China).

"Isolated CAS13 protein and use thereof" was invented by Junbin Liang (Guangzhou, China), Xingxiang Liang (Guangzhou, China), Yang Sun (Shaoxing, China), Hui Xu (Guangzhou, China), Zhiqin Peng (Guangzhou, China), Kaiwei Si (Guangzhou, China) and Desheng Huangfu (Guangzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to an isolated Cas13 protein and use thereof. The amino acid sequence of the isolated Cas13 protein comprises a sequence having less than=50% s...